Joerg Koglin

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also affiliated with Merck Institute for Science Education

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials”.

Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials

The Lancet(2025)10.1016/s0140-6736(25)01682-4

N/A

0.550DataRank · unranked

38 citations

Christopher M. O’Connor, Javed Butler, Ciaran J. McMullan, Kevin J. Anstrom, Irina Barash +84 more